Lena Scott
Science for Life Laboratory
35 Papers
106 Citations
Lena Scott is an academic researcher from Science for Life Laboratory. The author has contributed to research in topics: Receptor & Dopamine. The author has an hindex of 18, co-authored 35 publications. Previous affiliations of Lena Scott include Boston Children's Hospital & Karolinska Institutet.
Chat about Author
Papers
Super-resolution stimulated emission depletion imaging of slit diaphragm proteins in optically cleared kidney tissue
TL;DR: STED of slit diaphragms in fluorescently labeled, optically cleared, intact kidney samples is a new tool for studying the glomerular filtration barrier in health and disease.
93
Negative reciprocity between angiotensin II type 1 and dopamine D1 receptors in rat renal proximal tubule cells.
TL;DR: Results indicate that AT1R and D1R function as a unit of opposites, which should provide a highly versatile and sensitive system for short-term regulation of sodium excretion.
78
X-ray phase contrast for CO2 microangiography
Ulf Lundström,Daniel H. Larsson,Anna Burvall,Per Takman,Lena Scott,Hjalmar Brismar,Hans M. Hertz +6 more
TL;DR: A laboratory method for imaging small blood vessels using x-ray propagation-based phase-contrast imaging and carbon dioxide (CO(2)) gas as a contrast agent and the limited radiation dose in combination with CO(2) being clinically acceptable makes the method promising for small-diameter vascular visualization.
58
Developmental changes in frequency of the ciliary somatostatin receptor 3 protein.
TL;DR: The hypothesis that the ciliary SSTR3 is well positioned to influence the cell cycle and apoptotic processes during postnatal development, and in neurogenic regions of the adult rat brain is supported.
55
Prevention of apoptosis averts glomerular tubular disconnection and podocyte loss in proteinuric kidney disease
Ievgeniia Burlaka,Linnéa Nilsson,Lena Scott,Ulla Holtbäck,Ann-Christine Eklöf,Agnes B. Fogo,Hjalmar Brismar,Hjalmar Brismar,Anita Aperia +8 more
TL;DR: Ouabain is identified a novel clinically feasible therapeutic tool, which has the potential to protect from apoptosis and rescue from loss of functional tissue in chronic proteinuric kidney disease.
55